Perceived Self-Control is Related to Mental Distress in Patients Entering Substance Use Disorder Treatment

Abel, Kristine Fiksdal; Skjærvø, Ingeborg; Ravndal, Edle; Clausen, Thomas; Bramness, Jørgen G.

doi:10.1080/10826084.2017.1413114

Cited by 11 publications

(10 citation statements)

References 160 publications

(277 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In line with recent research [ 34 ] on the predictive relationship between mental health and self-control, the level of mental health symptoms and not variability predicted the subsequent self-control levels. This adds to the current knowledge from cross-sectional studies of substance use populations, where perceived self-control has been found to be associated with mental distress [ 32 , 35 ]. In addition, self-control outperformed mental health variables in predicting craving intensity and relapse status in time-lagged models in this sample, suggesting that self-control plays an important role as both targets for research, monitoring, and intervention.…”

Section: Discussionmentioning

confidence: 94%

“…The role of the affective state on impulsivity has previously been subject to thorough investigations as well as in the substance use population (i.e. [ 32 ]. Evidence suggests that increased mental health symptoms are related to decreased impulse control and hence has a detrimental effect on impulsive behaviors such as substance use [ 33 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Predicting Relapse in Substance Use: Prospective Modeling Based on Intensive Longitudinal Data on Mental Health, Cognition, and Craving

2022

View full text Add to dashboard Cite

Patients with severe substance use disorders are often characterized by neurocognitive impairments and elevated mental health symptom load, typically associated with craving intensity and substance use relapse. There is a need to improve the predictive capabilities of when relapse occurs in order to improve substance use treatment. The current paper contains data from 19 patients (seven females) in a long-term inpatient substance use treatment setting over the course of several weeks, with up to three weekly data collections. We collected data from 252 sessions, ranging from 1 to 24 sessions per subject. The subjects reported craving, self-control, and mental health on each occasion. Before starting the repeated data collection, a baseline neuropsychological screening was performed. In this repeated-measures prospective study, the mixed-effects models with time-lagged predictors support a model of substance use craving and relapse being predicted by the baseline reaction time as well as the temporal changes and variability in mental health symptom load, self-control, and craving intensity with moderate to high effect sizes. This knowledge may contribute to more personalized risk assessments and treatments for this group of patients.

show abstract

Section: Discussionmentioning

confidence: 94%

Section: Discussionmentioning

confidence: 99%

Predicting Relapse in Substance Use: Prospective Modeling Based on Intensive Longitudinal Data on Mental Health, Cognition, and Craving

2022

View full text Add to dashboard Cite

show abstract

“…The summed scale ranged from 0 to 15, with higher scores representing higher severity. The Hopkins Symptom Checklist 25-item version (HSCL-25) [ 36 ] was included as a measure of mental distress [ 37 ]. The version employed in our study used a 5-point Likert-type response format [ 38 , 39 ].…”

Section: Methodsmentioning

confidence: 99%

High smoking and low cessation rates among patients in treatment for opioid and other substance use disorders

2022

View full text Add to dashboard Cite

Background: Smoking is a well-documented cause of health problems among individuals with substance use disorders. For patients in opioid maintenance treatment (OMT), the risk for somatic health problems, including preventable diseases associated with tobacco smoking, increases with age. Our aim was to describe smoking among patients entering substance use disorder (SUD) treatment, investigate changes in smoking from the start of treatment to 1-year follow-up, and explore factors related to smoking cessation. Methods: We employed data from the Norwegian Cohort of Patient in Opioid Maintenance Treatment and Other Drug Treatment Study (NorComt). Participants were 335 patients entering SUD treatment at 21 participating facilities across Norway. They were interviewed at the start of treatment and at 1-year follow-up. The main outcomes were smoking and smoking cessation by treatment modality. A logistic regression identified factors associated with smoking cessation. Results: High levels of smoking were reported at the start of treatment in both OMT (94%) and other SUD inpatient treatment patients (93%). At 1-year follow-up most patients in OMT were still smoking (87%), and the majority of the inpatients were still smoking (69%). Treatment as an inpatient was positively associated and higher age was negatively associated with smoking cessation. Most patients who quit smoking transitioned to smokeless tobacco or kept their existing smokeless habit. Conclusion: As illustrated by the high smoking prevalence and relatively low cessation levels in our sample, an increased focus on smoking cessation for patients currently in OMT and other SUD treatment is warranted. Harm-reduction oriented smoking interventions may be relevant.

show abstract

“…Mental and behavioral disorders, including SUDs, represent the most common reason for nonparticipation in the Norwegian labor market, accounting for 61% of all disability benefits among young adults in 2015 [ 15 ]. For people in SUD treatment, national unemployment rates are extremely high, ranging from 81 to 91% [ 16 – 19 ]. IPS has been proven effective in Norway for people with moderate and severe mental disorders [ 20 , 21 ] and for young adults at risk of early work disability due to social- and health-related problems [ 22 ].…”

Section: Introductionmentioning

confidence: 99%

The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help

Rognli

Marius

Drake

et al. 2021

Trials

View full text Add to dashboard Cite

Background Employment is associated with better outcomes of substance use treatment and protects against relapse after treatment completion. Unemployment rates are high for people with substance use disorders (SUD) who undergo treatment, with Norwegian estimates ranging from 81 to 91%. Evidence-based vocational models are lacking for patients in SUD treatment but exist for patients with psychosis in terms of Individual Placement and Support (IPS). The aim of the IPS for substance use disorders (IPS-SUD) trial is to investigate the effect of IPS in a SUD population. Methods/design The IPS-SUD trial is a randomized controlled trial (RCT) comparing IPS to an enhanced control intervention. The study is a seven-site, two-arm, pragmatic, parallel-group, superiority RCT. Participants are randomly assigned (1:1) to receive either IPS plus treatment as usual (TAU) or to receive a self-help guide book and 12-h workshop plus 1-h individual vocational guidance plus TAU. Aiming to recruit 200 participants, we will be able to detect a 20% difference in the main outcome of employment with 90% power. We will make assessments at inclusion and at 6- and 12-month follow-ups and obtain outcome data on employment from national mandatory registries. The primary outcome will be at least 1 day of competitive employment during the 18-month follow-up period. Secondary employment outcomes will capture the pattern and extent of employment in terms of total time worked (days/hours), time to first employment, number of different jobs, duration of the longest employment, and sustained employment. Secondary non-employment outcomes will be substance use, mental distress, and quality of life measured by validated instruments at 6, 12, and 18 months follow-up assessments. To be eligible, participants must be between 18 and 65 years, currently unemployed and in treatment for SUD. Discussion The IPS-SUD trial will provide evidence for the use of IPS in a SUD population. Findings from the study will have implications for service delivery. Trial registration ClinicalTrials.gov NCT04289415. Registered on February 28, 2020

show abstract

Perceived Self-Control is Related to Mental Distress in Patients Entering Substance Use Disorder Treatment

Cited by 11 publications

References 160 publications

Predicting Relapse in Substance Use: Prospective Modeling Based on Intensive Longitudinal Data on Mental Health, Cognition, and Craving

Predicting Relapse in Substance Use: Prospective Modeling Based on Intensive Longitudinal Data on Mental Health, Cognition, and Craving

High smoking and low cessation rates among patients in treatment for opioid and other substance use disorders

The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help

Contact Info

Product

Resources

About